(3AS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde

Catalog No. :
ACCSLK934
CAS No. :
2459945-82-3
Molecular Formula :
C32H27NO
Molecular Weight :
441.57

IUPAC Name:(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde

(3AS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$601.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3AS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde
IUPAC Name(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde
Molecular FormulaC32H27NO
Molecular Weight441.57
SMILESO=CC1=CC2=C(N(C3=CC=C(C=C(C4=CC=CC=C4)C5=CC=CC=C5)C=C3)[C@]6([H])[C@@]2([H])CCC6)C=C1
InChI KeySYQNONGZPWUKAF-IZEXYCQBSA-N
SynonymCyclopent[b]indole-7-carboxaldehyde, 4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydro-, (3aS,8bS)-;(3aS,8bS)-4-(4-(2,2-Diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde - [D89345]
CAS No.2459945-82-3

Synthetic Route by SureRoute

1. ACCSLK934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCSLK934 route product structure diagram
    ACCSLK9342459945-82-3 In Stock
Inquiry

2. ACCSLK934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNVBK152 route compound structure diagram
    ACNVBK15218648-66-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCSLK934 route product structure diagram
    ACCSLK9342459945-82-3 In Stock
Inquiry

Comments (0)